[HTML][HTML] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal, MR Khan - BMC complementary and …, 2018 - Springer
Background Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

[PDF][PDF] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal, MR Khan - 2018 - researchgate.net
Background: Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue.

T Afsar, S Razak, A Almajwal… - BMC Complementary and …, 2018 - europepmc.org
Background Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

[HTML][HTML] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal… - BMC …, 2018 - bmccomplementmedtherapies …
Cisplatin (CP) drug is platinum compounds used for the treatment of various human
malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal… - BMC complementary …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

[HTML][HTML] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal… - BMC Complementary and …, 2018 - ncbi.nlm.nih.gov
Background Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

[引用][C] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal, MR Khan - BMC Complementary and …, 2018 - cir.nii.ac.jp
Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and
morphological alterations in rat pulmonary tissue | CiNii Research CiNii 国立情報学研究所 学術 …

[PDF][PDF] Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal, MR Khan - 2018 - academia.edu
Background: Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. Acacia …

Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue

T Afsar, S Razak, A Almajwal, MR Khan - BMC Complementary and …, 2018 - go.gale.com
Background Adverse treatment reactions due to antineoplastic agents are a common form of
iatrogenic injury [1], which prevails mostly in an idiosyncratic and indiscriminate manner …

Acacia hydaspica R. Parker ameliorates cisplatin induced oxidative stress, DNA damage and morphological alterations in rat pulmonary tissue.

T Afsar, S Razak, A Almajwal… - BMC Complementary & …, 2018 - search.ebscohost.com
Background: Cisplatin (CP) drug is platinum compounds used for the treatment of various
human malignancies. However, adverse outcomes related to CP restrict its usage. < …